• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PHYSIO II ANNULOPLASTY RING; RING, ANNULOPLASTY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PHYSIO II ANNULOPLASTY RING; RING, ANNULOPLASTY Back to Search Results
Model Number 5200
Device Problems Detachment of Device or Device Component (2907); Appropriate Term/Code Not Available (3191)
Patient Problems Mitral Regurgitation (1964); Organ Dehiscence (2502)
Event Date 04/27/2020
Event Type  Injury  
Manufacturer Narrative
Udi (b)(4).The device was not returned to edwards for evaluation.The device history record (dhr) was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.Ring dehiscence may occur early or late.When it occurs in the early post-operative period, it is typically a result of an inadequate valve repair in combination with friable myocardial tissue.Late dehiscence can occur as a result of successive dilatation of cardiac structures that result from progression of disease or from endocarditis.A manufacturing related issue was not identified.A definitive root cause could not be determined.If additional information is received a supplemental mdr will be submitted.Edwards lifesciences will continue to monitor all reported events.No further actions are required at this time.
 
Event Description
It was reported that a 28mm ring was explanted after six months due to dehiscence and severe eccentric mitral regurgitation.A 30mm ring was implanted in replacement.The mitral valve was interrogated showing no residual mitral regurgitation.The patient also received a 32mm 5200 ring in tricuspid position.The tricuspid valve was interrogated showing no residual tricuspid regurgitation.The patient tolerated the procedure well and was transferred to the icu in stable condition.The patient was discharged on pod #7 in good condition.There is no allegation of ring malfunction.
 
Manufacturer Narrative
H11.Corrected data- updated section h6 (conclusion).
 
Manufacturer Narrative
Corrected data: f10, h6.Reference capa-20-0014.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PHYSIO II ANNULOPLASTY RING
Type of Device
RING, ANNULOPLASTY
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key10121367
MDR Text Key194108594
Report Number2015691-2020-12067
Device Sequence Number1
Product Code KRH
Combination Product (y/n)N
PMA/PMN Number
K083470
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Type of Report Initial,Followup,Followup
Report Date 05/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/04/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/13/2024
Device Model Number5200
Was Device Available for Evaluation? No
Date Manufacturer Received07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age63 YR
-
-